Synopsis
Synopsis
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 7 Ethyl 10 Hydroxycamptothecin
2. 7-ethyl-10-hydroxycamptothecin
3. Camptosar
4. Camptothecin 11
5. Camptothecin-11
6. Cpt 11
7. Cpt-11
8. Cpt11
9. Irinotecan
10. Irrinotecan
11. Nk012 Compound
12. Sn 38
13. Sn 38 11
14. Sn-38
15. Sn-38-11
16. Sn3811
1. 100286-90-6
2. Irinotecan Hcl
3. Topotecin
4. Campto
5. Camptothecin 11 Hydrochloride
6. Camptosar
7. Cpt 11
8. Cpt-11
9. Irinotecan (hydrochloride)
10. Camptothecin 11
11. U 101440e
12. Chebi:5971
13. (s)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate Hydrochloride
14. Camptothecin Analog
15. 06x131e4oe
16. 7-ethyl-10-(4-(1-piperidino)-1-piperidino)carbonyloxy Camptothecin Hydrochloride
17. Nsc616348
18. Nsc-616348
19. Ncgc00095190-01
20. Dsstox_cid_25953
21. Dsstox_rid_81249
22. Dsstox_gsid_45953
23. [(19s)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;hydrochloride
24. Irinotecan Hydrochloride Anhydrous
25. Cas-100286-90-6
26. U-101440e
27. Unii-06x131e4oe
28. Irinotecan Hydrochloride [usan:jan]
29. Mfcd01862255
30. Irinotecanhydrochloride
31. Cpt-11 Hydrochloride
32. Irinotecan Monohydrochloride
33. Schembl4033
34. Camptosar (tn) (pharmacia)
35. (s)-[1,4'-bipiperidine]-1'-carboxylic Acid, 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl Ester Hydrochloride
36. Spectrum1505821
37. Chembl541887
38. Dtxsid6045953
39. Hms1922j04
40. Pharmakon1600-01505821
41. Amy24895
42. Bcp17234
43. Irinotecan Hydrochloride (anhydrous)
44. Tox21_111479
45. Hy-16562a
46. Nsc759878
47. S5026
48. Akos015901921
49. Tox21_111479_1
50. Ccg-213561
51. Irinotecan Hydrochloride [who-dd]
52. Ncgc00095190-02
53. Ncgc00178697-04
54. (1,4'-bipiperidine)-1'-carboxylic Acid, (4s)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl Ester, Monohydrochloride
55. (1,4'-bipiperidine)-1'-carboxylic Acid, 3,4,12,14-tetrahydro-4,11-diethyl-4-hydroxy-3,4-dioxo-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl Ester, Monohydrochloride, (s)-
56. Ac-28335
57. As-13304
58. I0714
59. Irinotecan Hydrochloride Anhydrous [mi]
60. Irinotecan Hydrochloride, Topoisomerase Inhibitor
61. 286i906
62. A897508
63. Sr-01000763864
64. Q-100016
65. Sr-01000763864-3
66. Q27106952
67. Z1550648758
68. (+)-7-ethyl-10-hydroxycamptothecine 10-(1,4'-bipiperidine)-1'-carboxylate, Monohydrochloride
69. (1,4'-bipiperidine)-1'-carboxylic Acid, (4s)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl Ester, Hydrochloride (1:1)
70. (19s)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl [1,4'-bipiperidine]-1'-carboxylate Hydrochloride
71. (4s)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylic Acid Ester Hydrochloride
72. (4s)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate Hydrochloride
73. (s)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl[1,4'-bipiperidine]-1'-carboxylatehydrochloride
74. [(19s)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate Hydrochloride
75. [1, 4,11-diethyl-3,4,12, 14-tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano[3',4':6,7] Indolizino[1,2-b]quinolin-9-yl Ester, Monohydrochloride (s)-
76. [1,4'-bipiperidine]-1'-carboxylic Acid,(4s)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl Ester, Monohydrochloride
77. 1-[1-({[(4s)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl]oxy}carbonyl)piperidin-4-yl]piperidin-1-ium Chloride
1. Camptosar
2. Campto
3. Irinotecan
4. Hy-16562
Molecular Weight | 623.1 g/mol |
---|---|
Molecular Formula | C33H39ClN4O6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 5 |
Exact Mass | 622.2558127 g/mol |
Monoisotopic Mass | 622.2558127 g/mol |
Topological Polar Surface Area | 113 Ų |
Heavy Atom Count | 44 |
Formal Charge | 0 |
Complexity | 1200 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Irinotecan hydrochloride |
Drug Label | Irinotecan hydrochloride injection is an antineoplastic agent of the topoisomerase I inhibitor class. Irinotecan hydrochloride was clinically investigated as CPT-11. Irinotecan hydrochloride injection is supplied as a sterile, pale yellow, clear, aqu... |
Active Ingredient | Irinotecan hydrochloride |
Dosage Form | Injectable |
Route | injection; Injection |
Strength | 20mg/ml; 100mg/5ml (20mg/ml); 500mg/25ml (20mg/ml); 100mg/5ml; 40mg/2ml (20mg/ml) |
Market Status | Prescription |
Company | Pliva Lachema; Hospira; Teva Parenteral; Fresenius Kabi Oncol; Accord Hlthcare; Jiangsu Hengrui Med; Hikma Farmaceutica; Teva Pharms Usa; Cipla; Hisun Pharm Hangzhou; Sun Pharma Global; Actavis Elizabeth; Emcure Pharms; Mustafa Nevzat Ilac; Fresenius Kabi |
2 of 2 | |
---|---|
Drug Name | Irinotecan hydrochloride |
Drug Label | Irinotecan hydrochloride injection is an antineoplastic agent of the topoisomerase I inhibitor class. Irinotecan hydrochloride was clinically investigated as CPT-11. Irinotecan hydrochloride injection is supplied as a sterile, pale yellow, clear, aqu... |
Active Ingredient | Irinotecan hydrochloride |
Dosage Form | Injectable |
Route | injection; Injection |
Strength | 20mg/ml; 100mg/5ml (20mg/ml); 500mg/25ml (20mg/ml); 100mg/5ml; 40mg/2ml (20mg/ml) |
Market Status | Prescription |
Company | Pliva Lachema; Hospira; Teva Parenteral; Fresenius Kabi Oncol; Accord Hlthcare; Jiangsu Hengrui Med; Hikma Farmaceutica; Teva Pharms Usa; Cipla; Hisun Pharm Hangzhou; Sun Pharma Global; Actavis Elizabeth; Emcure Pharms; Mustafa Nevzat Ilac; Fresenius Kabi |
Topoisomerase I Inhibitors
Compounds that inhibit the activity of DNA TOPOISOMERASE I. (See all compounds classified as Topoisomerase I Inhibitors.)
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-09-14
Pay. Date : 2013-09-05
DMF Number : 20649
Submission : 2007-06-29
Status : Active
Type : II
Certificate Number : CEP 2017-236 - Rev 02
Issue Date : 2023-09-22
Type : Chemical
Substance Number : 2675
Status : Valid
Registration Number : 220MF10025
Registrant's Address : Koivu-Mankkaan tie 6A, FI-02200 Espoo, Finland
Initial Date of Registration : 2008-01-23
Latest Date of Registration : --
NDC Package Code : 12780-4860
Start Marketing Date : 2007-06-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : TNS
Registration Date : 2022-01-13
Registration Number : 20220113-210-J-1177
Manufacturer Name : Fermion Oy
Manufacturer Address : Laaketehtaantie 2, Oulu, FI-90660, Finland
Sichuan Elixir Pharmaceutical, a manufacturer of small molecule APIs & a CMO/CDMO service provider for anti-tumor characteristic APIs..
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-12-21
Pay. Date : 2018-11-16
DMF Number : 21713
Submission : 2008-06-10
Status : Active
Type : II
Certificate Number : R1-CEP 2017-096 - Rev 00
Issue Date : 2023-04-24
Type : Chemical
Substance Number : 2675
Status : Valid
NDC Package Code : 61200-112
Start Marketing Date : 2015-05-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER, FOR SUSPENSION (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20195
Submission : 2007-01-12
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19222
Submission : 2006-03-06
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8553
Submission : 1990-05-02
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21272
Submission : 2008-01-22
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27724
Submission : 2013-12-19
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-14
Pay. Date : 2013-09-05
DMF Number : 20649
Submission : 2007-06-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17456
Submission : 2004-06-08
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18818
Submission : 2005-09-23
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2012-11-23
Pay. Date : 2012-11-09
DMF Number : 19050
Submission : 2005-12-20
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18969
Submission : 2005-10-30
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19661
Submission : 2006-07-27
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17312
Submission : 2004-04-20
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20195
Submission : 2007-01-12
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19222
Submission : 2006-03-06
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8553
Submission : 1990-05-02
Status : Inactive
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
(S)-8-Ethyl-8-hydroxy-2,3,5,8-tetrahydro-6-oxa-3a-...
CAS Number : 110351-94-5
End Use API : Irinotecan Hydrochloride
About The Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commer...
2’-Amino-5’-hydroxypropiophenone
CAS Number : 35364-15-9
End Use API : Irinotecan Hydrochloride
About The Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commer...
7-Ethyl-10-hydroxycamptothecin (SN-38)
CAS Number : 86639-52-3
End Use API : Irinotecan Hydrochloride
About The Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commer...
2’-Amino-5’-hydroxypropiophenone (AHP)
CAS Number : 35364-15-9
End Use API : Irinotecan Hydrochloride
About The Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commer...
CAS Number : 4897-50-1
End Use API : Irinotecan Hydrochloride
About The Company : Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for...
CAS Number : 4897-50-1
End Use API : Irinotecan Hydrochloride
About The Company : Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for...
4-Piperidinylpiperidine dihydrochloride
CAS Number : 4876-60-2
End Use API : Irinotecan Hydrochloride
About The Company : Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for...
4-Piperidinylpiperidine dihydrochloride
CAS Number : 4876-60-2
End Use API : Irinotecan Hydrochloride
About The Company : Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for...
CAS Number : 4897-50-1
End Use API : Irinotecan Hydrochloride
About The Company : Established in 2003 with small pilot plant and came in to commercial production in 2013 in the name of Allchem Laboratories, it is an independent privately owne...
CAS Number : 19685-09-7
End Use API : Irinotecan Hydrochloride
About The Company : Chengdu Yazhong Bio-pharmaceutical Co., Ltd., founded in 2002, is a leading company with plant extracts, APIs and medical intermediates. Our company is equipped...
Regulatory Info :
Registration Country : Italy
Brand Name : Irinotecan
Dosage Form : Irinotecan 500Mg 25Ml 1 Units Parenteral Use
Dosage Strength : 1 vial EV 500 mg 25 ml 20 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Sweden
Brand Name : Irinokabi
Dosage Form : CONCENTRATE FOR SOLUTION FOR INFUSION
Dosage Strength : 20 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Irinokabi
Dosage Form : Concentrate to the infusion fluid
Dosage Strength : 20 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Irinotecan The Fresenius Kabi
Dosage Form : Concentrate to the infusion fluid, resolution
Dosage Strength : 20 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Italy
Brand Name : Irinotecan
Dosage Form : Irinotecan 100Mg 5Ml 1 Units Parenteral Use
Dosage Strength : 1 vial EV 100 mg 5 ml 20 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Switzerland
Irinotecani Hydrochloridum Trihydricum
Brand Name : Irinotecan Labatec
Dosage Form : Inf Conc
Dosage Strength : 40mg/2ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Irinotecani Hydrochloridum Trihydricum
Brand Name : Irinotecan Labatec
Dosage Form : Inf Conc
Dosage Strength : 300mg/15ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Irinotecani Hydrochloridum Trihydricum
Brand Name : Campto
Dosage Form : Inf Konz
Dosage Strength : 100mg/5ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Irinotecani Hydrochloridum Trihydricum
Brand Name : Irinotecan-Teva liquid
Dosage Form : Inf Conc
Dosage Strength : 100mg/5ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Sweden
Brand Name : Irinotecan Mylan
Dosage Form : CONCENTRATE FOR SOLUTION FOR INFUSION
Dosage Strength : 20 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Dosage Form : Concentrate to the infusion flui...
Dosage Strength : 20 mg/ml
Price Per Pack (Euro) : 85.008
Published in :
Country : Norway
RX/OTC/DISCN :
Dosage Form : Concentrate to the infusion flui...
Dosage Strength : 20 mg/ml
Price Per Pack (Euro) : 203.36
Published in :
Country : Norway
RX/OTC/DISCN :
Dosage Form : Concentrate to the infusion flui...
Dosage Strength : 20 mg/ml
Price Per Pack (Euro) : 600.59
Published in :
Country : Norway
RX/OTC/DISCN :
Dosage Form : Concentrate to the infusion flui...
Dosage Strength : 20 mg/ml
Price Per Pack (Euro) : 997.81
Published in :
Country : Norway
RX/OTC/DISCN :
The Fresenius Kabi Oncology Plc
Dosage Form : Concentrate to the infusion flui...
Dosage Strength : 20 mg/ml
Price Per Pack (Euro) : 85.008
Published in :
Country : Norway
RX/OTC/DISCN :
The Fresenius Kabi Oncology Plc
Dosage Form : Concentrate to the infusion flui...
Dosage Strength : 20 mg/ml
Price Per Pack (Euro) : 203.36
Published in :
Country : Norway
RX/OTC/DISCN :
The Fresenius Kabi Oncology Plc
Dosage Form : Concentrate to the infusion flui...
Dosage Strength : 20 mg/ml
Price Per Pack (Euro) : 600.59
Published in :
Country : Norway
RX/OTC/DISCN :
The Fresenius Kabi Oncology Plc
Dosage Form : Concentrate to the infusion flui...
Dosage Strength : 20 mg/ml
Price Per Pack (Euro) : 997.81
Published in :
Country : Norway
RX/OTC/DISCN :
Dosage Form : Concentrate to the infusion flui...
Dosage Strength : 20 mg/ml
Price Per Pack (Euro) : 85.008
Published in :
Country : Norway
RX/OTC/DISCN :
Dosage Form : Concentrate to the infusion flui...
Dosage Strength : 20 mg/ml
Price Per Pack (Euro) : 203.36
Published in :
Country : Norway
RX/OTC/DISCN :
Market Place
Patents & EXCLUSIVITIES
Exclusivity Code : ODE-463
Exclusivity Expiration Date : 2031-02-13
Application Number : 207793
Product Number : 1
Exclusivity Details :
Exclusivity Code : I-932
Exclusivity Expiration Date : 2027-02-13
Application Number : 207793
Product Number : 1
Exclusivity Details :
Patent Expiration Date : 2015-10-11
Date Granted : 2005-05-03
Brand Name : CAMPTOSAR
Patent Number : 2202531
Filing Date : 1995-10-11
Strength per Unit : 20 mg / ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Injectable
Patent Expiration Date : 2015-10-11
Date Granted : 2005-05-03
Patent Expiration Date : 2018-07-27
Date Granted : 2005-01-18
Brand Name : CAMPTOSAR
Patent Number : 2294031
Filing Date : 1998-07-27
Strength per Unit : 20 mg / ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Injectable
Patent Expiration Date : 2018-07-27
Date Granted : 2005-01-18
Patent Expiration Date : 2005-04-19
Date Granted :
Brand Name :
Patent Number : 1235415
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2005-04-19
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
REF. STANDARDS & IMPURITIES
Irinotecan Related Compound E (15 mg) ((S)-4,...
CAS Number : 78287-27-1
Quantity Per Vial :
Price ($) : 730
Catalog Number : 1347664
Current Lot : F0L059
Previous Lot :
NDC Code :
Irinotecan Related Compound D (15 mg) ((R)-9-...
CAS Number : N/A
Quantity Per Vial :
Price ($) : 805
Catalog Number : 1347653
Current Lot : R02530
Previous Lot : G0L060 (31-OCT-2016)
NDC Code :
Irinotecan Related Compound C (10 mg) (11-Eth...
CAS Number : N/A
Quantity Per Vial :
Price ($) : 730
Catalog Number : 1347642
Current Lot : G0K219
Previous Lot : F0I280 (31-JAN-2013)
NDC Code :
Irinotecan Related Compound B (10 mg) ((S)-4,...
CAS Number : 86639-52-3
Quantity Per Vial :
Price ($) : 730
Catalog Number : 1347631
Current Lot : R01310
Previous Lot : F0I264 (31-MAY-2015)
NDC Code :
Irinotecan Related Compound A (10 mg) ((S)-4-...
CAS Number : 19685-09-7
Quantity Per Vial :
Price ($) : 805
Catalog Number : 1347610
Current Lot : R05430
Previous Lot : R011Y0 (31-JUL-2018)
NDC Code :
Irinotecan Hydrochloride (100 mg)
CAS Number : 136572-09-3
Quantity Per Vial :
Price ($) : 365
Catalog Number : 1347609
Current Lot : R022P0
Previous Lot : G0J233 (30-SEP-2015)
NDC Code :
CAS Number : 143490-53-3
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : I0007.19
Irinotecan Related Compound A (10 mg) ((S)-4-...
CAS Number : 19685-09-7
Quantity Per Vial : 10
Sale Unit : mg
Price : $835.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1347610 / R05430
Irinotecan Related Compound B (10 mg) ((S)-4,...
CAS Number : 86639-52-3
Quantity Per Vial : 10
Sale Unit : mg
Price : $775.00
Details : Material Origin- Plant -Synthetic; USMCA- No;...
Monograph :
Storage :
Code/Batch No : Catalog #1347631 / R107V0
Irinotecan Related Compound C (10 mg)(11-Ethy...
CAS Number :
Quantity Per Vial : 10
Sale Unit : mg
Price : $814.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1347642 / R107W 0
Irinotecan Related Compound D (15 mg) ((R)-9-...
CAS Number :
Quantity Per Vial : 15
Sale Unit : mg
Price : $919.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1347653 / R11160
Irinotecan Related Compound E (15 mg) ((S)-4,...
CAS Number : 78287-27-1
Quantity Per Vial : 15
Sale Unit : mg
Price : $775.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1347664 / R124P0
Irinotecan Hydrochloride (100 mg)
CAS Number : 136572-09-3
Quantity Per Vial : 100
Sale Unit : mg
Price : $390.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1347609 / R10230
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?